Literature DB >> 15645191

[Drug allergies. Clinical aspects, pathophysiology and treatment of cutaneous manifestations].

B Sachs1, H F Merk.   

Abstract

Cutaneous adverse drug reactions (ADR) are common and encompass a broad clinical spectrum. Since the skin acts as a signaling organ for ADR, the dermatologist plays a key role in their diagnosis. Only a minor part of cutaneous ADR are due to underlying allergic mechanisms. Among these, delayed-type reactions such as maculopapular exanthems and immediate-type reactions such as urticaria and angioedema predominate. Risk factors for the development of cutaneous allergic ADR may be related to the patient (e.g. certain HLA-types), the drug (e.g. its reactivity), and underlying conditions (e.g. viral infections). Antibiotics, non-steroidal anti-inflammatory agents and anticonvulsive medications are most often reported to be causally related.

Entities:  

Mesh:

Year:  2005        PMID: 15645191     DOI: 10.1007/s00105-004-0880-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   1.198


  28 in total

Review 1.  Hepatic cytochrome P450 regulation in disease states.

Authors:  P Y Cheng; E T Morgan
Journal:  Curr Drug Metab       Date:  2001-06       Impact factor: 3.731

2.  Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug.

Authors:  B D Klassen; R M Sadler
Journal:  Epilepsia       Date:  2001-03       Impact factor: 5.864

3.  Distinct serum cytokine levels in drug- and measles-induced exanthema.

Authors:  Y Hari; A Urwyler; M Hurni; N Yawalkar; C Dahinden; T Wendland; L R Braathen; L Matter; W J Pichler
Journal:  Int Arch Allergy Immunol       Date:  1999-11       Impact factor: 2.749

Review 4.  An innate sense of danger.

Authors:  P Matzinger
Journal:  Semin Immunol       Date:  1998-10       Impact factor: 11.130

Review 5.  Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.

Authors:  S R Knowles; L E Shapiro; N H Shear
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

Review 6.  The rational clinical examination. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy.

Authors:  A R Salkind; P G Cuddy; J W Foxworth
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

7.  Combined in vivo and in vitro approach for the characterization of penicillin-specific polyclonal lymphocyte reactivity: tolerance tests with safe penicillins instead of challenge with culprit drugs.

Authors:  B Sachs; T Al Masaoudi; H F Merk; S Erdmann
Journal:  Br J Dermatol       Date:  2004-10       Impact factor: 9.302

8.  Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India.

Authors:  V K Sharma; G Sethuraman; B Kumar
Journal:  J Postgrad Med       Date:  2001 Apr-Jun       Impact factor: 1.476

9.  Self-reported drug allergy in a general adult Portuguese population.

Authors:  E Gomes; M F Cardoso; F Praça; L Gomes; E Mariño; P Demoly
Journal:  Clin Exp Allergy       Date:  2004-10       Impact factor: 5.018

10.  Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

Authors:  S G O Johansson; Thomas Bieber; Ronald Dahl; Peter S Friedmann; Bobby Q Lanier; Richard F Lockey; Cassim Motala; Jose A Ortega Martell; Thomas A E Platts-Mills; Johannes Ring; Frank Thien; Paul Van Cauwenberge; Hywel C Williams
Journal:  J Allergy Clin Immunol       Date:  2004-05       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.